Barrett, The Honors College Thesis/Creative Project Collection
Barrett, The Honors College at Arizona State University proudly showcases the work of undergraduate honors students by sharing this collection exclusively with the ASU community.
Barrett accepts high performing, academically engaged undergraduate students and works with them in collaboration with all of the other academic units at Arizona State University. All Barrett students complete a thesis or creative project which is an opportunity to explore an intellectual interest and produce an original piece of scholarly research. The thesis or creative project is supervised and defended in front of a faculty committee. Students are able to engage with professors who are nationally recognized in their fields and committed to working with honors students. Completing a Barrett thesis or creative project is an opportunity for undergraduate honors students to contribute to the ASU academic community in a meaningful way.
Displaying 1 - 7 of 7
Filtering by
- Creators: School of Life Sciences
Description
In the United States, the prevalence of pediatric obesity has increased to 17% in the general population and even more so in the Hispanic pediatric population to 22.4%. These children are at a higher risk for associated comorbidities, including cardiovascular disease and insulin resistance. The purpose of the following study is to determine the effectiveness of the Nutrition and Health Awareness curriculum at reducing childhood obesity by evaluating alterations in the gut microbial composition, diet, and overall health of the students throughout the five-week program. Nutrition and Health Awareness (NHA) is a student organization that strives to reduce the prevalence of obesity, diabetes, and cardiovascular diseases, specifically in children, by providing active nutrition education services through peer mentoring in elementary schools and community programs. This study went through ASU's Institutional Review Board process and all forms were translated into Spanish. The control group maintained their normal routines and the experimental group received the 5 week NHA program and then continued with their normal routines. Anthropometric measures (Body Mass Index, waist-to-hip ratio, and blood pressure), diet measures (Hispanic food frequency questionnaire), fecal swabs, and content surveys were collected on weeks 0, 5, and 8. Contrary to expected, alpha diversity, kilocalorie intake, and macronutrient intake decreased as the study progressed for both the control and experimental groups. Anthropometric measurements were relatively stable. Though not statistically significant, the greatest difference in time points is between weeks 1 and 8. This decrease in alpha diversity and kilocalorie intake could be due to a change in environment since the children started school on week 8. Future implications of this study are that parental involvement is necessary for an effective, sustainable change in these children. More research in different settings is necessary to determine NHA's effectiveness
ContributorsPatel, Kapila Cristina (Author) / Krajmalnik-Brown, Rosa (Thesis director) / Whisner, Corrie (Committee member) / School of Nutrition and Health Promotion (Contributor) / School of Life Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2016-05
Description
Microorganisms can produce metabolites in the gut including short chain fatty acids, vitamins, and amino acids. Certain metabolites produced in the gut can affect the brain through changes in neurotransmitter concentrations. Serotonin, a neurotransmitter, is associated with mood, appetite, and sleep. Up to 90% of serotonin synthesis is located in the gut, by human enterochromaffin cells. Bacteria known to biosynthesize tryptophan, precursor to serotonin, include Escherichia coli, Enterococcus and Streptococcus. Tryptophan is synthesized by bacteria with the enzyme tryptophan synthase and requires Vitamin B6 (Pyridoxal). We hypothesize that gut isolates from surgical weight loss patients can enhance tryptophan production, which relies on vitamin B6 availability. Our goal was to isolate bacteria in order to test for tryptophan production and to determine how Vitamin B6 concentrations could affect tryptophan production. We isolated gut bacteria was from successful surgical weight loss patient with selective pressures for Enterobacter isolates and Enterococcus isolates. We tested the isolates were tested to determine if they could biosynthesize tryptophan in-vitro. Bacterial cultures were enriched with yeast and enriched with serine and indole, substrates necessary for tryptophan biosynthesis. We analyzed the supernatant samples for tryptophan production using GC-FID. Bacterial isolates most closely related to E. coli and Klebsiella based on 16S rRNA gene sequences, produced tryptophan in vitro. While under serine & indole media conditions, R1, the isolate most similar to Klebsiella produced more tryptophan than R14, the isolate most similar to E. coli. We tested the R1 isolate with a gradient of vitamin B6 concentrations from 0.02 µg/mL to 0.2 µg/mL to determine its effect on tryptophan production. When less than 0.05 µg/mL of Vitamin B6 was added, tryptophan production at 6 hours was higher than tryptophan production with Vitamin B6 concentrations at 0.05 µg/mL and above. The production and consumption of tryptophan by Klebsiella under 0 µg/mL and 0.02 µg/mL concentrations of Vitamin B6 occurred at a faster rate when compared to concentrations 0.05 µg/mL or higher of Vitamin B6.
ContributorsYee, Emily L. (Author) / Krajmalnik-Brown, Rosa (Thesis director) / Ilhan, Zehra (Committee member) / W. P. Carey School of Business (Contributor) / School of Life Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2016-05
Description
The effect of an anaerobic reductive environment produced by the oxidation of zero valent iron (ZVI) on the microbial reductive dechlorination of trichloroethylene and its applicability to in-situ bioremediation processes was investigated using microcosms and soil column studies. I learned that microbial dechlorination requires a highly reductive environment, as represented by negative values for oxidation-reduction potential (ORP), which can be maintained through the addition of reducing agents such as ZVI, or to a lesser extent, the fermentation of added substrates such as lactate. Microcosm conditions represented distance from an in-situ treatment injection well and contained different types of iron species and dechlorinating bioaugmentation cultures. Diminishing efficacy of microbial reductive dechlorination along a gradient away from the injection zone was observed, characterized by increasing ORP and decreasing pH. Results also suggested that the use of particular biostimulation substrates is key to prioritizing the dechlorination reaction against competing microbial and abiotic processes by supplying electrons needed for microbial dechlorination.
ContributorsMouti, Aatikah (Author) / Krajmalnik-Brown, Rosa (Thesis director) / Delgado, Anca (Committee member) / School of Life Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2017-12
Description
The human gut microbiome is a complex community of microorganisms. These microbes play an important role in host health by contributing essential compounds and acting as a barrier against pathogens. However, these communities and associated functions can be impacted by factors like disease and diet. In particular, microbial fermentation of dietary components like polysaccharides, proteins, and fats that reach the gut are being examined to better understand how these biopolymers are utilized and affect community structure. Thus, evaluating the accuracy of methods used to quantify specific macromolecules is crucial to gaining a precise understanding of how gut microbes hydrolyze those substrates. This study presents findings on the accuracy of the Megazyme RS kit (Rapid) modified for high performance liquid chromatography (HPLC) readings and the DC Protein Assay when performed on samples from complex gut media with potato starch treatments and bovine serum albumin (BSA) treatments. Overall, our data indicates that the megazyme RS kit needs further modification to detect expected starch content with the HPLC and that the DC Protein Assay is not suitable for specific protein analysis.
ContributorsKlein, Rachel Marie (Author) / Krajmalnik-Brown, Rosa (Thesis director) / Marcus, Andrew (Committee member) / School of Life Sciences (Contributor) / School of International Letters and Cultures (Contributor) / Barrett, The Honors College (Contributor)
Created2021-05
Description
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that not only affects communication and behavior with often co-occurring gastrointestinal (GI) issues such as constipation and diarrhea. Recent studies have shown that many GI and behavioral symptoms in individuals with ASD are linked to dysregulated immune systems and altered gut microbiomes (bacteria and fungi). In fungal microbiota, a common GI commensal and opportunistic pathogen, Candida, has been found in higher abundance in children with ASD. Few studies have investigated total IgA and IgG levels in both blood and feces of ASD individuals with relatively mixed findings, showing either significantly higher or lower IgG and IgA abundance in ASD vs. TD (typically developing) individuals. Mixed results are likely due to a lack of a standardized method of immunoglobulin (Ig) quantification. In this study, we attempt to standardize an enzyme-linked immunoassay (ELISA) procedure to measure total IgA, total IgG, and anti-Candida albicans IgA and IgG levels in fecal samples of adults with ASD. Measuring Ig levels can reflect altered gut microbiota, GI tract, and immune status in ASD and potentially characterize Ig as a biomarker for ASD. Although we were unable to successfully standardize an Ig ELISA quantification method, SDS-PAGE confirmed the presence of IgA in fecal Ig extracts. Based on our ELISA results, we suspect that dilution factors of fecal Ig extracts need to be modified further to detect the IgA within the detection range. The experimental methodology in this study can be used as a reference to develop and improve a full-proof method of quantifying immunoglobulin from ASD fecal samples, which will help to reveal immune status in ASD.
ContributorsMarwah, Mira (Author) / Campos, Nicole (Co-author) / Krajmalnik-Brown, Rosa (Thesis director) / Nirmalkar, Khemlal (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor) / Department of Psychology (Contributor)
Created2022-05
Description
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that not only affects communication and behavior with often co-occurring gastrointestinal (GI) issues such as constipation and diarrhea. Recent studies have shown that many GI and behavioral symptoms in individuals with ASD are linked to dysregulated immune systems and altered gut microbiomes (bacteria and fungi). In fungal microbiota, a common GI commensal and opportunistic pathogen, Candida, has been found in higher abundance in children with ASD. Few studies have investigated total IgA and IgG levels in both blood and feces of ASD individuals with relatively mixed findings, showing either significantly higher or lower IgG and IgA abundance in ASD vs. TD (typically developing) individuals. Mixed results are likely due to a lack of a standardized method of immunoglobulin (Ig) quantification. In this study, we attempt to standardize an enzyme-linked immunoassay (ELISA) procedure to measure total IgA, total IgG, and anti-Candida albicans IgA and IgG levels in fecal samples of adults with ASD. Measuring Ig levels can reflect altered gut microbiota, GI tract, and immune status in ASD and potentially characterize Ig as a biomarker for ASD. Although we were unable to successfully standardize an Ig ELISA quantification method, SDS-PAGE confirmed the presence of IgA in fecal Ig extracts. Based on our ELISA results, we suspect that dilution factors of fecal Ig extracts need to be modified further to detect the IgA within the detection range. The experimental methodology in this study can be used as a reference to develop and improve a full-proof method of quantifying immunoglobulin from ASD fecal samples, which will help to reveal immune status in ASD.
ContributorsCampos, Nicole (Author) / Marwah, Mira (Co-author) / Krajmalnik-Brown, Rosa (Thesis director) / Nirmalkar, Khemlal (Committee member) / Barrett, The Honors College (Contributor) / Sanford School of Social and Family Dynamics (Contributor) / School of Life Sciences (Contributor)
Created2022-05
Description
Autism spectrum disorder (ASD) currently lacks a biological diagnostic test, ongoing research is being conducted to develop a urine biomarker test for autism. Researchers are investigating possible anions, such as sulfur-based anions, as a biomarker for autism. Although studies have not measured the quantification of sulfate-based anions within a biospecimen while using Ion Chromatography (IC) for a 24-hour period. Research studies on autism biomarker development could greatly benefit by investigating and quantifying sulfur-based anions such as sulfate, sulfide, sulfite, or thiosulfate. Our research investigated the quantifications of anions through the analysis of biospecimens across 24-hours in an IC. The results of our research indicate that sulfate fluctuates the least and was consistently read by the IC at each time point across 24 hours whereas the other anions of interest presented greater fluctuations and were not detected at each time point across the 24 hours under the conditions tested.
ContributorsPauls, Frank (Author) / Krajmalnik-Brown, Rosa (Thesis director) / Westerhoff, Paul (Committee member) / Bellinghiere, Andrew (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor) / School of Human Evolution & Social Change (Contributor)
Created2024-05